Targeted Immunotherapy in the Treatment of Childhood and Adolescent Classic Hodgkin Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 10, p. 520
- By:
- Publication type:
- Article
Works matching IS 15430790 AND DT 2024 AND VI 22 AND IP 10
Results: 8
1
2
The Emergence of Bispecific T-Cell Engagers in the Treatment of Follicular and Large B-Cell Lymphomas.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 10, p. 510
- By:
- Publication type:
- Article
3
Circulating Tumor DNA in Early-Stage Breast Cancer: Ready for the Clinic?
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 10, p. 507
- By:
- Publication type:
- Article
4
Incorporating PSMA PET Imaging Into the Treatment Plan for Newly Diagnosed and Recurrent Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 10, p. 497
- By:
- Publication type:
- Article
5
Choosing Between CAR T-Cell Therapy and Pirtobrutinib in Double-Refractory CLL.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 10, p. 494
- By:
- Publication type:
- Article
6
The Use of Zenocutuzumab for NRG1 Fusion-Positive Tumors.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 10, p. 487
- By:
- Publication type:
- Article
7
What Will Be the Next Partner for Combination Immunotherapy With Nivolumab and Ipilimumab?
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 10, p. 483
- By:
- Publication type:
- Article
8
Who's Your Advocate?
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 10, p. 470
- By:
- Publication type:
- Article